Form 8-K - Current report:
SEC Accession No. 0001437749-26-016983
Filing Date
2026-05-14
Accepted
2026-05-14 14:00:30
Documents
14
Period of Report
2026-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ftlf20260514_8k.htm   iXBRL 8-K 27506
2 EXHIBIT 99.1 ex_963216.htm EX-99.1 339934
7 logo.jpg GRAPHIC 10200
  Complete submission text file 0001437749-26-016983.txt   534798

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ftlf-20260514.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ftlf-20260514_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ftlf-20260514_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ftlf-20260514_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT ftlf20260514_8k_htm.xml XML 2831
Mailing Address 5214 S. 136TH STREET OMAHA NE 68137
Business Address 5214 S. 136TH STREET OMAHA NE 68137 402-884-1894
FITLIFE BRANDS, INC. (Filer) CIK: 0001374328 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41803 | Film No.: 26977753
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)